Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer

March 17, 2026 updated by: Mayo Clinic
This study uses ambient sensing rooms to collect data from hospitalized cancer patients in order to improve safety and recovery. Being hospitalized increases the risk for delirium (acute confusion), falls, troubles sleeping, and mood changes. Ambient sensing rooms are special rooms that use technology including a video camera to watch the room, an audio recorder to listen to sounds, and a temperature sensor (thermography) to check how warm or cool the room and people are. These tools may help nurses and doctors notice problems early, give better care, and keep patients safe and comfortable.

Study Overview

Study Type

Observational

Enrollment (Estimated)

134

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Nursing Research Study Team
  • Phone Number: 507-422-5523

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Recruiting
        • Mayo Clinic in Rochester
        • Contact:
        • Contact:
          • Nursing Research Study Team
          • Phone Number: 507-422-5523
        • Principal Investigator:
          • Allyson K. Palmer, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients with cancer or history of cancer diagnosis admitted to ambient intelligent rooms and clinicians participating in direct patient care activities.

Description

Inclusion Criteria:

  • Patients:

    • Age >= 18
    • Not receiving comfort/end-of-life care
    • Not incarcerated
    • Admitted to one of the six rooms equipped with ambient technology
    • History of cancer or has a cancer diagnosis
  • Clinicians:

    • Age >= 18
    • Participating in direct patient care activities on Eisenberg units 4-3 as an employee of Mayo Clinic

Exclusion Criteria:

  • Patients:

    • Age < 18 years
    • Receiving comfort or end-of-life care
    • Incarceration (prisoner status)
    • Primary language is not English
  • Clinicians:

    • Age < 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Observational group I
Patients complete a questionnaire, have ambient sensor data collected for the duration of their stay in the ambient sensing room, participate in an interview, and have their medical records reviewed on study.
Non-interventional study
Other Names:
  • Non-Interventional Observational Study
  • Noninterventional (Observational) Study
Observational group II
Clinicians participate in a focus group on study.
Non-interventional study
Other Names:
  • Non-Interventional Observational Study
  • Noninterventional (Observational) Study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complete hospital timeline
Time Frame: Up to 1 year
Will develop a complete hospital timeline that integrates input from video, audio, thermography, and patient-reported symptoms. This multimodal hospital timeline will illustrate patterns of care that result from system and human interaction.
Up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Allyson K Palmer, MD, PhD, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2026

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

October 31, 2027

Study Registration Dates

First Submitted

March 11, 2026

First Submitted That Met QC Criteria

March 13, 2026

First Posted (Actual)

March 17, 2026

Study Record Updates

Last Update Posted (Actual)

March 19, 2026

Last Update Submitted That Met QC Criteria

March 17, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 25-011005

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malignant Solid Neoplasm

Clinical Trials on Non-Interventional Study

Subscribe